News
Gemtesa Approved for Overactive Bladder Treatment
The approval was based on data from the pivotal phase 3 EMPOWUR study.
Your search for hypertension returned 621 results
News
NSAID Use Among US Adults With Cardiovascular Disease Examined
Cross-sectional data from the National Health and Nutrition Examination Survey from 1988 to 1994 and 1999 to 2016 were used for this analysis.
News
Saxenda Approved for Obesity in Adolescent Patients
The FDA has approved Saxenda® (liraglutide; Novo Nordisk) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in patients aged 12 years and older with body weight >60kg and an initial BMI corresponding to ≥30kg/m2 for adults (obese).
News
Gavreto Gets Accelerated Approval for RET-Altered Thyroid Cancers
The approval was based on data from the phase 1/2 ARROW trial which evaluated the efficacy and safety of Gavreto in patients with RET-mutant MTC.
News
Novel Treatment Gains Accelerated Approval for Relapsed/Refractory Neuroblastoma
Approval was based on results from two phase 2 single-arm, open-label trials that demonstrated overall response rate and duration of response.
News
FDA Approves Oxlumo for Primary Hyperoxaluria Type 1
Lumasiran is an investigational ribonucleic acid interference therapeutic that inhibits hepatic production of oxalate by targeting hydroxyacid oxidase 1.
News
First Treatment for Progeria Gets FDA Approval
Zokinvy works by preventing farnesylation and subsequent accumulation of progerin and progerin-like proteins in the inner nuclear membrane.
Drugs in the Pipeline
Long-Acting Cabotegravir Gets Breakthrough Therapy Status for HIV PrEP
Results from the final analysis showed that cabotegravir was 66% more effective than FTC/TDF in preventing HIV acquisition.
News
FDA Identifies Most Needed Meds to Address Urgent Medical Conditions
This action was in response to an executive order issued on August 6, 2020 aimed at protecting the public against outbreaks of emerging diseases and chemical, biological, radiological, and nuclear threats.
News
Novel Medication Relieves Pruritus in Hemodialysis Cases
Difelikefalin, an investigational intravenous drug, improved moderate to severe itching compared with placebo in patients on hemodialysis, according to phase 3 trial results.
